(415) 514-1641 (appts)
(415) 353-1200 (fax)

Box 0102, UCSF; San Francisco, CA 94143-0102

additional websites:

UCSF Physician Referral Directory

Seattle University, Seattle, WA, B.S., 1975-1979, Biology and Chemistry
Duke University, Durham, NC, M.D. and Ph.D., 1979-1985, Medicine/Immunology
Duke University Medical Center, Durham, NC, 1986, Internal Medicine
Brigham and Women's Hospital, Boston, MA, 1986-1992, Anatomic & Clinical Pathology

Full articles

Treseler, P.A., and Clark, O.H. Prognostic factors in thyroid carcinoma. Surg Oncol Clin North Am. 6: 555-598; 1997.

Russo, D., Wong, M.G., Costante, G., Chiefari, E., Treseler, P.A., Arturi, F., Filetti, S, and Clark, O.H. A val-677 activating mutation of the thyrotropin receptor in a HÙrthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid 9: 13-17; 1999.

Kebebew, E., Treseler, P.A., Siperstein, A.E., Duh, Q.-Y., and Clark, O.H. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RET gene germline mutation: a report of three cases and a review of the literature. Thyroid 9: 127-131; 1999.

J.E. Vaquerano, Cadbury, P., Treseler, P., Sagebiel, R., and Leong, S.P.L. Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF); a brief report. Arch Dermatol 135: 1276-1277; 1999.

Perrier, N.D., Ituarte, P.H.G., Treseler, P., D"Avanzo, A., Siperstein, A., Duh, Q.Y., and Clark, O.H. Classification and treatment of follicular thyroid neoplasms are discordant between and within medical specialties. Surgery 126: 1063-1069; 1999.

Leong, S.P.L., Morita, E., Treseler, P., and Wong, J. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Cancer 7: 105-113; 2000.

Thelmo, M.C., Sagebiel, R.W., Treseler, P.A., Morita, E.T., Nguyen, L.H., Kashani-Sabet, M., and Leong, S.P.L. Evaluation of sentinel lymph node status in spindle cell melanoma. J Am Acad Derm In press.

Treseler, P.A., and Tauchi, P.S. Pathologic analysis of the sentinel lymph node. Surg Clin North Am 80: 1695-1719; 2000.

Leong, S.P.L., Nwakanma, L., Achtem, T.A., Morita, E., Sokol, S.C., Treseler, P., Kuerer, H.M., Hwang, E., and Esserman, L. Evolving techniques in the identification and mapping of breast cancer sentinel lymph nodes. Submitted for publication.

Leong, S.P.L., Achtem, T., Steinmetz, I., Habib, F.A., Abbey, K.R., Miller, J., Allen, R.E., Morita, E., Treseler, P., Mraz, S., Kashani-Sabet, M., and Sagebiel, R. Micrometastases in sentinel lymph nodes is a strong predictor of recurrence and death from metastatic melanoma. Submitted for publication.

Jensen, R.H., Tiirikainen, M., You, L., Treseler, P., and Jablons, D.M. Genomic alterations in human malignant mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q. Submitted for publication.

You, L., Yang, C.T., Zang, K., Xie, J.W., Treseler, P., Moody, T., McCormick, F., and Jablons, D.M. Profiling of differentially expressed genes in human malignant pleural mesothelioma. Submitted for publication.

Treseler, P.A., Song, J., Ituarte, P.H.G., David, G., Clary-Macy, C., You, L., and Jablons, D.M. Immunoreactivity for p53 and bcl-2 proteins predicts survival in patients with malignant pleural mesothelioma. Submitted for publication.

D'Avanzo, A., Ituarte, P., Treseler, P., Kebebew, E., Wu, J., Wong, M., Duh, Q.-Y., Siperstein, A.E., and Clark, O.H.: Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Submitted for publication.

Alsanea, O., Wada, N., Ain, K., Wong, M., Taylor, K., Ituarte, P., Treseler, P., Weier, H.-U., Freimer, N., Siperstein, A.E., Duh, Q.-Y., Takami, H., and Clark, O.H.: Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer: a multi-center study. Submitted for publication.

Kebebew, E., Treseler, P.A., Duh, Q.-Y., Clark, O.H.: The helix-loop transcription factor, ID1, is overexpressed in medullary thyroid cancer. Submitted for publication.

Abstracts

Sato, F., Wong, M.G., Treseler, P.A., Siperstein, A.E., Duh, Q.-Y., and Clark, OH: Homozygous deletion of multiple tumor suppressor-1 gene (MTS-1) in parathyroid disease. Western Regional Meeting of American Federation for Medical Research, p68A, Monterey, February 1998.

Song, J.M., Treseler, P., You, L., Clary-Macy, C., and Jablons, D.M. Tumor angiogenesis and microvessel counts in malignant mesothelioma. American College of Chest Physicians, 10th Cardiac and General Thoracic Surgery Update, St. Thomas, VI, Abstract No. 41, Dec. 1998.

Leong, S.P.L., Achtem, T.A., Steinmetz, I., Habib, F.A., Abbey, K.R., Miller, J., Allen, R.E., Morita, E., Treseler, P., Mraz, S., Kashani-Sabet, M., and Sagebiel, R. Micrometastasis in sentinel lymph nodes is a strong predictor of recurrence and death from metastatic melanoma. ASCO Proc, 1999.

Leong, S.P.L., Nguyen, L., Achtem, T., Miller, J., Ituarte, P., Steinmetz, I., Treseler, P., Allen, R., Morita, E., Mraz, S., Kashini-Sabet, M., and Sagebiel, R. Clinical significance of melanoma micrometastasis to sentinel lymph nodes and other high risk factors. ASCO Proc, 2000.

Treseler, P.A., Song, J.M., David, G., Clary-Macy, C., You, L., and Jablons, D.M. Expression of p53 protein in malignant pleural mesothelioma: correlation with prognosis. Mod Pathol 13: 217A; 2000. (United States and Canadian Academy of Pathology, 89th Annual Meeting, March 2000)

Treseler, P.A., D'Avanzo, A., Perrier, N., Ituarte, P., and Clark, O.H. Histopathologic prognostic factors in follicular thyroid carcinoma: an attempt to quantify grading. Mod Pathol 13: 74A; 2000. (United States and Canadian Academy of Pathology, 89th Annual Meeting, March 2000)

Kebebew, E., Treseler, P.A., Duh, Q.-Y., and Clark, O.H.: The helix-loop transcription factor, ID1, is overexpressed in medullary thyroid cancer. British Association of Endocrine Surgeons/American Association of Endocrine Surgeons, London, England & Lille, France, #1145, May, 2000.

Alsanea, O., Wada, N., Ain, K., Wong, M., Taylor, K., Ituarte, P., Treseler, P., Weier, H.-U., Freimer, N., Siperstein, A.E., Duh, Q.-Y., Takami, H., Clark, O.H. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer: a multi-center study. British Association of Endocrine Surgeons/American Association of Endocrine Surgeons, London, England & Lille, France, #1545, May, 2000.

Heerema, A. and Treseler, P. Beta-catenin expression in B-cell neoplasms: Evidence for dendritic cell pathogenesis in Hodgkin's disease. Mod Pathol 14: 165A; 2001. (United States and Canadian Academy of Pathology, 90th Annual Meeting, March 2001)

Rabban, J., Mihok, N., Jones, K., Cha, I., Sudilovsky, D., Ferrell, L., and Treseler, P. Small metastases in breast cancer sentinel lymph nodes are not consistently identified without keratin stains. Mod Pathol 14: 230A; 2001. (United States and Canadian Academy of Pathology, 90th Annual Meeting, March 2001)

Treseler, P., and Rabban, J. Clinical significance of micrometastases in breast sentinel lymph nodes. Mod Pathol 14: 39A; 2001. (United States and Canadian Academy of Pathology, 90th Annual Meeting, March 2001)

Niewmierzycka, S., Heerema, A. and Treseler, P. B-cell lymphomas fail to express DR5, a major cell receptor in p53-mediated apoptosis. Mod Pathol 14: 174A; 2001. (United States and Canadian Academy of Pathology, 90th Annual Meeting, March 2001)

12/01